TCM has informed that the Board of Directors of the Company in its meeting held on Tuesday, 11th November, 2025 has considered and approved the following business: The Consolidated and Standalone Unaudited Financial Results of the Company along with the Consolidated and Standalone Limited Review Reports for the Quarter ended 30th September 2025. The meeting commenced at 10.30 AM and concluded at 12:00 PM. Pursuant to Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, they are enclosing the Unaudited Standalone and Consolidated Financial Results for the first quarter ended 30th September 2025 along with a copy of Limited Review Reports issued by the Auditors of the Company.
The above information is a part of company’s filings submitted to BSE.
